Aleksandar Jelic
Founding Partner at HNC Capital
Munich, Bavaria
Aleksandar Jelic, Founding Partner at HNC Capital is an active investor based in Munich, Bavaria. This profile covers what Aleksandar Jelic backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VC
- Stages
- SeedSeries A
- Invests in
- SaaS & Enterprise
- Location
- Munich, Bavaria
- Typical check
- $625K
How to reach Aleksandar Jelic
Angels and operators like Aleksandar Jelic reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.
Connect with Aleksandar Jelic
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise.
Frequently Asked Questions
What does Aleksandar Jelic invest in?
Aleksandar Jelic invests in SaaS & Enterprise, typically at Seed and Series A. Match your sector and stage, then reach out with a personalized pitch.
What stage does Aleksandar Jelic invest at?
Aleksandar Jelic typically invests at Seed and Series A. Lead with traction that fits the stage when you reach out.
What is Aleksandar Jelic's typical check size?
Aleksandar Jelic typically writes checks around $625K. Use it as a signal for whether your raise fits their stage.
How do I contact Aleksandar Jelic?
Unlock Aleksandar Jelic's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.